Título : |
Effective treatment of refractory pulmonary hemorrhage with monoclonal anti-CD20 antibody |
Tipo de documento : |
documento electrónico |
Autores : |
Juan Ignacio Marín Zuluaga, ; Inés Elena Pachón Grajales, |
Fecha de publicación : |
2009 |
Títulos uniformes : |
Respiration
|
Idioma : |
Inglés (eng) |
Resumen : |
We report a 19-year-old female with systemic lupus erythematosus and lupus nephritis who developed pulmonary hemorrhage (PH) refractory to conventional immunosuppressive treatment. She was initially treated with intravenous methylprednisolone and cyclophosphamide pulses. She required mechanical ventilation due to a lack of responsiveness and her disease was considered refractory to conventional treatment. Rituximab was administered and this was followed by clinical improvement in both PH and nephritis. Rituximab may be a useful therapeutic option for the treatment of refractory PH. |
Mención de responsabilidad : |
Luis Fernando Pinto, Liliana Candia, Patricia Garcia, Juan Ignacio Marín, Ines Pachón, Luis R Espinoza, Javier Marquez |
Referencia : |
Respiration. 2009;78(1):106-9. |
DOI (Digital Object Identifier) : |
10.1159/000156965 |
PMID : |
18799870 |
En línea : |
https://www.karger.com/Article/Abstract/156965 |
Enlace permanente : |
https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4444 |
Effective treatment of refractory pulmonary hemorrhage with monoclonal anti-CD20 antibody [documento electrónico] / Juan Ignacio Marín Zuluaga, ; Inés Elena Pachón Grajales, . - 2009. Obra : RespirationIdioma : Inglés ( eng) Resumen : |
We report a 19-year-old female with systemic lupus erythematosus and lupus nephritis who developed pulmonary hemorrhage (PH) refractory to conventional immunosuppressive treatment. She was initially treated with intravenous methylprednisolone and cyclophosphamide pulses. She required mechanical ventilation due to a lack of responsiveness and her disease was considered refractory to conventional treatment. Rituximab was administered and this was followed by clinical improvement in both PH and nephritis. Rituximab may be a useful therapeutic option for the treatment of refractory PH. |
Mención de responsabilidad : |
Luis Fernando Pinto, Liliana Candia, Patricia Garcia, Juan Ignacio Marín, Ines Pachón, Luis R Espinoza, Javier Marquez |
Referencia : |
Respiration. 2009;78(1):106-9. |
DOI (Digital Object Identifier) : |
10.1159/000156965 |
PMID : |
18799870 |
En línea : |
https://www.karger.com/Article/Abstract/156965 |
Enlace permanente : |
https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4444 |
| |